Recent work has highlighted stabilin-1 upregulaton in TAMs in a range of cancers, and in an in vivo model of breast cancer the uptake of SPARC, a tumour inhibiting factor, by stabilin-1 on TAMs promoted tumor progression [79]. This evidence concerns the gene STAB1 and cancer.